相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Role of Obesity in Female Reproduction
Wei Yong et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2023)
What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
Kimio Watanabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
NF-KB dynamics in the language of immune cells
Mohammad Aqdas et al.
TRENDS IN IMMUNOLOGY (2023)
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Clifford J. Bailey et al.
CURRENT DIABETES REPORTS (2022)
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management
Lei Peng et al.
STEM CELL RESEARCH & THERAPY (2022)
Role of nitric oxide in type 1 diabetes-induced osteoporosis
Sajad Jeddi et al.
BIOCHEMICAL PHARMACOLOGY (2022)
IL-6 and its role in IgA nephropathy development
Yaroslava Groza et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2022)
Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway
Wei Gu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle et al.
KIDNEY INTERNATIONAL (2022)
Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation
Ryan L. Kan et al.
TRENDS IN GENETICS (2022)
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies
Haojia Wu et al.
CELL METABOLISM (2022)
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
Takashi Kadowaki et al.
DIABETES OBESITY & METABOLISM (2022)
Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway
Di Jin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2022)
NF-?B: blending metabolism, immunity, and inflammation
Daria Capece et al.
TRENDS IN IMMUNOLOGY (2022)
The relationship between insulin and glucagon concentrations in non-diabetic humans
Marcello C. Laurenti et al.
PHYSIOLOGICAL REPORTS (2022)
Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
Petra Hyrossova et al.
CELL DEATH & DISEASE (2022)
The role of circular RNA in Diabetic Nephropathy
Chao Tu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)
Roles of melatonin in the field of reproductive medicine
Wei Yong et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Radica Z. Alicic et al.
NATURE REVIEWS NEPHROLOGY (2021)
Effects of High Glucose and Lipotoxicity on Diabetic Podocytes
Ran Nakamichi et al.
NUTRIENTS (2021)
Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine
Wumei Wei et al.
FRONTIERS IN PHARMACOLOGY (2021)
Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering
Fei Teng et al.
ADVANCED SCIENCE (2021)
The Inhibition of Metabolic Inflammation by EPA Is Associated with Enhanced Mitochondrial Fusion and Insulin Signaling in Human Primary Myotubes
Domenico Sergi et al.
JOURNAL OF NUTRITION (2021)
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial
Melanie Davies et al.
LANCET (2021)
被撤回的出版物: BMSCs-derived exosomal microRNA-let-7a plays a protective role in diabetic nephropathy via inhibition of USP22 expression (Retracted article. See vol. 318, 2023)
Ruiyang Mao et al.
LIFE SCIENCES (2021)
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2021)
Update on diagnosis, pathophysiology, and management of diabetic kidney disease
Mai Sugahara et al.
NEPHROLOGY (2021)
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
Guoyi Tang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Non-Coding RNA and Diabetic Kidney Disease
Huiwen Ren et al.
DNA AND CELL BIOLOGY (2021)
Tubuloglomerular Feedback Synchronization in Nephrovascular Networks
Tayyaba Zehra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1
Yan Hao et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Application of mesenchymal stem cell-derived exosomes in kidney diseases
Deng Gang et al.
CELLULAR IMMUNOLOGY (2021)
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
Cristian Loretelli et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Insulin resistance, cardiovascular stiffening and cardiovascular disease
Michael A. Hill et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Extracellular vesicles as a next-generation drug delivery platform
Inge Katrin Herrmann et al.
NATURE NANOTECHNOLOGY (2021)
The Mesangial cell - the glomerular stromal cell
Shimrit Avraham et al.
NATURE REVIEWS NEPHROLOGY (2021)
Targeting the Pathobiology of Diabetic Kidney Disease
Merlin C. Thomas
ADVANCES IN CHRONIC KIDNEY DISEASE (2021)
Oxidative stress, nutritional antioxidants and beyond
Qiuping Guo et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
The future of stem cell therapies for Parkinson disease
Malin Parmar et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine
Guida Bento et al.
CELLS (2020)
Next-generation stem cells - ushering in a new era of cell-based therapies
Erin A. Kimbrel et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy
Yurui Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Pluripotent Stem Cell-Based Cell Therapy- Promise and Challenges
Shinya Yamanaka
CELL STEM CELL (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hyperglycemia Induces Endoplasmic Reticulum Stress in Atrial Cardiomyocytes, and Mitofusin-2 Downregulation Prevents Mitochondrial Dysfunction and Subsequent Cell Death
Ming Yuan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
Maura Knapp et al.
ACTA PHARMACOLOGICA SINICA (2019)
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
Yajuan Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Stem cells: past, present, and future
Wojciech Zakrzewski et al.
STEM CELL RESEARCH & THERAPY (2019)
Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte
Juan Jin et al.
STEM CELL RESEARCH & THERAPY (2019)
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders
Milad Riazifar et al.
ACS NANO (2019)
Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)
Loubna Mazini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
Javier Donate-Correa et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Exosomes
D. Michiel Pegtel et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies
Zizhen Si et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The roles of microRNAs in epigenetic regulation
Qian Yao et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Exosomal microRNA‐16‐5p from human urine‐derived stem cells ameliorates diabetic nephropathy through protection of podocyte
Yu‐Rui Duan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
Carl Randall Harrell et al.
CELLS (2019)
Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy
Cristina Grange et al.
SCIENTIFIC REPORTS (2019)
Inflammation in Diabetic Kidney Disease
Rosa E. Perez-Morales et al.
NEPHRON (2019)
Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers
Tao Huang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
SGLT2 inhibition and kidney protection
Josselin Nespoux et al.
CLINICAL SCIENCE (2018)
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg et al.
DIABETOLOGIA (2018)
Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity
Jana Grune et al.
HYPERTENSION (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
Maria Angela Incalza et al.
VASCULAR PHARMACOLOGY (2018)
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy
Chun-Wu Tung et al.
NEPHROLOGY (2018)
Therapy resistance mediated by cancer stem cells
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2018)
Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway
Nesrine Ebrahim et al.
CELLS (2018)
Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
Keith Gillis et al.
CLINICAL KIDNEY JOURNAL (2018)
CTGF in kidney fibrosis and glomerulonephritis
Naohiro Toda et al.
INFLAMMATION AND REGENERATION (2018)
Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
Katherine R. Tuttle
DIABETES (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Qidi Ying et al.
RENAL FAILURE (2017)
Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy
Kanna Nagaishi et al.
SCIENTIFIC REPORTS (2017)
The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1
Li Xiao et al.
REDOX BIOLOGY (2017)
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes
Micheal S. Ward et al.
SCIENTIFIC REPORTS (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives
Eva Feigerlova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
Pascal Bus et al.
DIABETOLOGIA (2017)
Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy
Mixuan Yi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Stem cell-based therapies for HIV/AIDS
Olivier Pernet et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
The Players: Cells Involved in Glomerular Disease
A. Richard Kitching et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
Paul M. Palevsky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell
Li Sun et al.
CYTOTHERAPY (2016)
Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
Bo Wang et al.
MOLECULAR THERAPY (2016)
Nephron Protection in Diabetic Kidney Disease
Hans-Joachim Anders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats
Zhen-zhen Jiang et al.
STEM CELL RESEARCH & THERAPY (2016)
Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting
Sara Gallo et al.
PLOS ONE (2016)
Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
Kanna Nagaishi et al.
SCIENTIFIC REPORTS (2016)
Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1
Rui Peng et al.
GENE (2015)
Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium
Yingjie Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
Tyson Smyth et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Exosomes in cancer: small particle, big player
Xu Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa et al.
NATURE MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Diabetic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
Robyn Cunard
JOURNAL OF CLINICAL MEDICINE (2015)
VEGF-A Inhibition Ameliorates Podocyte Apoptosis via Repression of Activating Protein 1 in Diabetes
Xiaoyan Bai et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Modeling human neurological disorders with induced pluripotent stem cells
Yoichi Imaizumi et al.
JOURNAL OF NEUROCHEMISTRY (2014)
After the banquet Mitochondrial biogenesis, mitophagy, and cell survival
Jianhui Zhu et al.
AUTOPHAGY (2013)
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer
Vladimir N. Anisimov et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells
Eun-Hee Nam et al.
CARCINOGENESIS (2012)
The role of autophagy in unilateral ureteral obstruction rat model
Wan-Young Kim et al.
NEPHROLOGY (2012)
Therapeutic potential of mesenchymal stem cell-derived microvesicles
Luigi Biancone et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study
Belinda Jim et al.
PLOS ONE (2012)
TGF-β/BMP Pathways and the Podocyte
Irini Tossidou et al.
SEMINARS IN NEPHROLOGY (2012)
VEGF and Podocytes in Diabetic Nephropathy
Alda Tufro et al.
SEMINARS IN NEPHROLOGY (2012)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions
Abdoljalal Marjani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2011)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease
Fangfang Peng et al.
DIABETES (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy
G. H. Tesch
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy
Gunter Wolf et al.
NEPHRON PHYSIOLOGY (2007)
The role of TNF-α in diabetic nephropathy:: Pathogenic and therapeutic implications
Juan F. Navarro et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Signalling and regulation of collagen I synthesis by ET-1 and TGF-β1
A Horstmeyer et al.
FEBS JOURNAL (2005)
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade:: A short-term, randomized, controlled trial
JF Navarro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
Y Moriwaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)